Abstracts - Society for Developmental Biology
Abstracts - Society for Developmental Biology
Abstracts - Society for Developmental Biology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
95<br />
Program/Abstract # 290<br />
A molecular and genetic approach to identifying a clinical rabbit craniosynostotic model and its relevance to<br />
craniofacial development<br />
Gallo, Phillip, University of Pittsburgh, Pittsburgh, United States; Cray Jr, James (Augusta, GA, United States); Durham,<br />
Emily; Losee, Joseph; Mooney, Mark; Cooper, Gregory; Kathju, Sandeep (Pittsburgh, PA, United States)<br />
Craniosynostosis, the premature fusion of the sutures of the cranial vault, clinically manifests with a range of severity from<br />
subclinical phenotypes to severe cases, exhibiting increased intracranial pressure, severely altered head shape, and<br />
premature death. Much of what is known about craniosynostosis is derived from studies in animal models and human<br />
mutations in trans<strong>for</strong>ming growth factor beta receptors (TgfβRs), fibroblast growth factor receptors (FGFRs), Twist1, and<br />
Msx2; these mutations, however, only account <strong>for</strong> 15 % of known craniosynostosis cases in humans. We have previously<br />
described a colony of rabbits with an autosomal dominant heritable pattern of coronal suture synostosis. We undertook a<br />
molecular analysis todetermine whether TgfβR1, TgfβR2, FGFR1, FGFR2 and / or Twist1 were the loci ofthe causative<br />
mutation within our model system using single nucleotide polymorphisms (SNPs); SNPs were identified within our colony<br />
through cDNA and genomic DNA cloning and sequencing. These SNPs were assayed <strong>for</strong> segregation with disease<br />
phenotype in 22craniosynostotic animals. SNP analysis within the TgfβR1, TgfβR2, FGFR1, FGFR2, and Twist1 genes<br />
indicated that none of these loci are linked to the craniosynostotic phenotype as no allelic combination showed any specific<br />
correlation with disease phenotype. As no SNP arrays exist <strong>for</strong> rabbits, we sought a molecular /bioin<strong>for</strong>matics method to<br />
create a SNP map in rabbits with the ultimate goal of mapping the defect in our rabbit colony. Utilizing recent<br />
advancements in next generation sequencing, we used the recently published restriction site associated DNA sequencing<br />
technique (RADsequencing) to identify SNPs in our rabbit genome compared to wild type animals maintained separately<br />
from our breeding colony. This analysis described over 60,000 SNPs within our animals that can be mapped to the lowdensity<br />
rabbit genome currently available. Subsequent bioin<strong>for</strong>matics analysis identified approximately 6,000 SNPs that<br />
map to the craniosynostotic colony, an important first step in identifying genes that segregate with the craniosynostosis<br />
phenotype <strong>for</strong> future mapping purposes. Since we have already ruled out five genes known to be involved in cranio<br />
synostosis, this well-established clinical model provides a unique opportunity to decipher the molecular pathways<br />
functioning in craniofacial development.<br />
Program/Abstract # 291<br />
Effect of low molecular weight chitosan oligosaccharides reduces pulmonary fibrosis in a Bleomycin mouse model<br />
Hong, Heejoo, Gachon University, Inchon, Korea, Republic of; Kim, Ji sun; Kim, Sung Won; Park, Soo Jong; Park,<br />
Cheol Ho; Park, Jae Kweon; Hwang, You Hin; Kim, Dae Yong (Gachon University, Inchon, Republic of Korea)<br />
In human, idiopathic pulmonary fibrosis is characterized by alveolar epithelial cell injury and lose its functions. This<br />
disease leads to impairment of gas exchange and pulmonary function because of the loss of lung elasticity and alveolar<br />
surface area. Bleomycin is limited because it produces dose-dependent pulmonary toxicity which induces interstitial<br />
pulmonary fibrosis. Low molecular weight chitosan oligosaccharides (LM-COS) has effects of anti-inflammatory. LM-<br />
COS (